Brian Roman
General Counsel chez VIATRIS INC.
Fortune : 2 M $ au 31/03/2024
Profil
Brian S.
Roman is currently the Global General Counsel at Viatris, Inc. since 2020.
Prior to this, he worked as the Vice President & General Counsel at Mylan Pharmaceuticals, Inc.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
VIATRIS, INC.
0,01% | 04/03/2024 | 157 142 ( 0,01% ) | 2 M $ | 31/03/2024 |
Postes actifs de Brian Roman
Sociétés | Poste | Début |
---|---|---|
VIATRIS INC. | General Counsel | 16/11/2020 |
Anciens postes connus de Brian Roman
Sociétés | Poste | Fin |
---|---|---|
Mylan Pharmaceuticals, Inc.
Mylan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mylan Pharmaceuticals, Inc. develops and manufactures generic prescription products. Its product includes tablets, Fosamax, Sectral, Xanax, capsules, liquids, and transdermal patches. The company was founded in 1961 and is headquartered in Morgantown, WV. | General Counsel | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
VIATRIS INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Mylan Pharmaceuticals, Inc.
Mylan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mylan Pharmaceuticals, Inc. develops and manufactures generic prescription products. Its product includes tablets, Fosamax, Sectral, Xanax, capsules, liquids, and transdermal patches. The company was founded in 1961 and is headquartered in Morgantown, WV. | Health Technology |